Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral Palsy

Launched by ANAHUAC UNIVERSITY · Dec 5, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how a special nutritional support system (NSS) can help improve movement and control in children with spastic cerebral palsy, a condition that affects muscle control and coordination. The goal is to find out if better nutrition can lead to better neuromotor skills in these patients. The trial is currently looking for participants aged 4 to 11 years who have a specific level of mobility impairment (classified as GMFCS III), can follow instructions, and tolerate oral feeding.

If your child is eligible and you decide to participate, you can expect regular assessments to monitor their progress and how the nutritional support may impact their abilities. It's important to know that some children won't qualify, such as those who have had certain treatments or surgeries recently, or those with other serious health conditions. This study aims to provide valuable insights into how nutrition can play a role in the development of children with cerebral palsy, potentially leading to better outcomes in their movement and overall health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with GMFCS III classification.
• • Patients with spastic CP.
• • Both sexes age 4 to 11 years.
• • Primary caregiver engaged (full presence).
• • Able to follow instructions.
• • Tolerant to oral feeding.
• • Parents or guardians to sign informed consent letter.
• • Children, if able to write, sign the letter of assent.
• Exclusion Criteria:
• • Have received antibiotics 15 days prior to treatment.
• • Having received botulinum toxin therapy in the last six months. Consumption of muscle relaxants in the last three months.
• • Patient with any type of surgery in a period of less than 6 months.
• • Presence of any other catabolic disease, which further increases their risk of malnutrition (renal, cardiovascular, pulmonary, hepatic, immunological).
• • Intolerance to oral feeding.
• • Lack of stimulation at home.
• • Moderate to severe gastroesophageal reflux.
• • Able to walk without support.

Trial Officials